Leica Biosystems acquired San Diego-based Cell IDx, Inc. Terms of the deal were not disclosed.
Founded in 2012, Cell IDx provides multiplex staining panels, tissue staining and imaging and analysis services.
Buffalo Grove, Illinois-based Leica Biosystems is a cancer diagnostics company and a global leader in workflow solutions.
In 2021, Leica Biosystems and Cell IDx announced a partnership to combine the benefits of UltraPlex and BOND RX.
According to the LevinPro HC database, this was the 123rd Biotechnology transaction of 2022. This compares with 103 Biotechnology deals recorded between January 1, 2021, and November 10, 2021.
